脱毛治療の世界市場 (2019-2029年)：タイプ・性・エンドユーザー・地域別の市場規模・シェア・動向分析・機会・予測

世界の脱毛治療の市場規模は、2022年の244億1,000万米ドルから、予測期間中は4.48％のCAGRで推移し、2029年には329億3,000万米ドルの規模に成長すると予測されています。

市場の主な成長要因としては、世界人口における脱毛症の有病率の増加、人口の急速な高齢化、ライフスタイルの変化、脱毛治療に対する認識と受容度の向上などが挙げられます。最近では、ハーブオイルやシャンプー、サプリメントなど、天然素材やハーブを使った治療が人気を集めています。技術の進歩により、レーザーキャップやヘルメット、頭皮マイクロピグメンテーション、血小板リッチプラズマセラピーなど、革新的な脱毛対策が開発されています。また、可処分所得の増加や美意識の向上への欲求も育毛製品への需要の増加をもたらしています。

当レポートでは、世界の脱毛治療の市場を調査し、市場概要、市場成長への各種影響因子の分析、技術動向、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の脱毛治療市場に関する洞察

• 業界のバリューチェーン分析
• DROC分析
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
• 製品の進歩/最近の開発
• 規制の枠組み
• ポーターのファイブフォース分析

第4章 世界の脱毛治療市場：概要

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
    • 製品
    • 薬剤
  • 性別
    • 男性
    • 女性
  • エンドユーザー別
    • 皮膚科クリニック
    • 病院
    • 在宅ケア
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第5章 北米の脱毛治療市場

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
  • 性別
  • エンドユーザー別
  • 国別

第6章 欧州の脱毛治療市場

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
  • 性別
  • エンドユーザー別
  • 国別

第7章 アジア太平洋の脱毛治療市場

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
  • 性別
  • エンドユーザー別
  • 国別

第8章 ラテンアメリカの脱毛治療市場

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
  • 性別
  • エンドユーザー別
  • 国別

第9章 中東・アフリカの脱毛治療市場

• 市場規模・予測
• 市場シェア・予測
  • タイプ別
  • 性別
  • エンドユーザー別
  • 国別

第10章 競合情勢

• 主要企業・製品リスト
• 市場シェア分析
• 競合ベンチマーキング：経営パラメーター別
• 主要な戦略的展開 (M&A・提携など)

第11章 世界の脱毛治療市場に対するCOVID-19の影響

第12章 企業プロファイル (企業概要・財務マトリックス・競合情勢・主要人材・主な競合相手・連絡先・戦略的展望・SWOT分析)

• Merck & Co., Inc.
• Johnson & Johnson
• Dr. Reddy's Laboratories Ltd.
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Histogen Inc.
• Concert Pharmaceuticals, Inc.
• Aclaris Therapeutics, Inc.
• Follicum AB
• Polichem S.A.
• Cassiopea SpA
• PureTech Health
• Kythera Biopharmaceuticals, Inc.
• Kerastem Technologies
• HairClone
• その他の主要企業

第13章 主な戦略的提言

第14章 調査手法

Global Anti-Hair Loss Medicine Market Size Steadily Raising to Touch USD 33 Billion by 2029.

Global anti-hair loss medicine market is flourishing because of a spurring demand for personalized hair loss treatment, increasing prevalence of hair loss, and the availability of a wide range of hair loss treatments and products.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global anti-hair loss medicine market size at USD 24.41 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global anti-hair loss medicine market size to grow at a steady CAGR of 4.48% reaching a value of USD 32.93 billion by 2029. Major growth factors of global anti-hair loss medicine market include increasing prevalence of alopecia or hair loss among the global population, rapidly aging population, changing lifestyles, and increasing awareness and acceptance of hair loss treatments. Hair loss can be caused by various factors, such as genetics, hormonal imbalances, stress, and medical conditions. Consequently, there is a considerable demand for effective treatments and remedies to prevent or reverse hair loss. Recently, the use of natural and herbal remedies for hair loss, including herbal oils, shampoos, and supplements, has been gaining popularity. The advancement of technology has led to the development of innovative hair loss solutions, such as laser caps and helmets, scalp micropigmentation, and platelet-rich plasma therapy. Also, the rise in disposable incomes and the desire for improved aesthetics have resulted in an increased demand for hair restoration products. Hence, boosting the expansion of global anti-hair loss medicine market during the forecast period. However, limited efficacy of some hair loss medicines and social stigma associated with hair loss leading to a reluctance to seek treatment are anticipated to restrain the growth of global anti-hair loss medicine market.

Global Anti-Hair Loss Medicine Market - Overview:

The anti-hair loss medicine market refers to the industry that involves the development, manufacturing, and marketing of pharmaceuticals and other treatments designed to prevent or reduce hair loss or alopecia. Hair loss has become a significant concern for many individuals in today's world due to various internal factors, such as hormonal imbalances, major illnesses, aging, and others. The market for hair loss treatment products is growing rapidly as there is a rising demand for treatments for androgenetic alopecia, a hair problem that affects women, men, and children, leading to baldness and requiring medication. For instance, the American Academy of Dermatology reports that more than 40% of women globally experience hair loss issues by age 40 due to hormonal imbalances and other reasons. Additionally, increasing stress levels resulting from the ever-changing lifestyles have contributed significantly to the prevalence of hair loss. As the demand for hair loss treatment products continues to rise globally, manufacturers are introducing new and innovative products to address this concern. By targeting conscious consumers and revitalizing their product portfolios, manufacturers are aiming to attain a larger market share. As a result, the global anti-hair loss medicine market is expected to experience significant growth in the coming years.

Impact of COVID-19 on Global Anti-Hair Loss Medicine Market

COVID-19 had a detrimental impact on the global anti-hair loss medicine market. The pandemic disrupted supply chains and caused significant economic slowdowns, leading to a decrease in demand for non-essential products, including hair loss treatment products. Lockdowns and social distancing measures also affected the availability of hair loss treatment services, such as hair transplant surgeries and in-clinic treatments, which led to a shift towards home-based treatments and products. However, the pandemic also led to increased stress levels, which can exacerbate hair loss. It drove demand for hair loss treatment products, particularly those that can be used at home.

Global Anti-Hair Loss Medicine Market - By Type:

Based on type, the global anti-hair loss medicine market is bifurcated into Product and Medicine segments. The product segment holds a higher share in the global anti-hair loss medicine market by type. The product segment includes shampoo & conditioner, oil, and serum. The shampoo conditioner segment holds the highest market share, while the oils segment is expected to record the highest compound annual growth rate (CAGR) during the forecast period. The popularity of shampoos and conditioners is due to their widespread use, and the unisex segment was the most widely used. On the other hand, the men's segment is expected to witness growth at a higher CAGR during the forecast period, primarily driven by the increasing demand for hair loss prevention products among young men. While most manufacturers offer a range of unisex hair care products, such as shampoos, conditioners, oils, and serums, they are now revitalizing their product portfolios to target specific customers by introducing new products at affordable prices to gain a larger market share.

Competitive Landscape:

Major players operating in global anti-hair loss medicine market include: Merck & Co., Inc., Johnson & Johnson, Dr. Reddy's Laboratories Ltd., Cipla Inc., Sun Pharmaceutical Industries Ltd., Histogen Inc., Concert Pharmaceuticals, Inc., Aclaris Therapeutics, Inc., Follicum AB, Polichem S.A., Cassiopea SpA, PureTech Health, Kythera Biopharmaceuticals, Inc., Kerastem Technologies, and HairClone. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Anti-Hair Loss Medicine Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Anti-Hair Loss Medicine Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Anti-Hair Loss Medicine Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing prevalence of hair loss among the global population
    • 3.2.1.2. Availability of a wide range of hair loss treatments and products
    • 3.2.1.3. Rising demand for personalized hair loss treatment solutions
  • 3.2.2. Restraints
    • 3.2.2.1. Limited efficacy of some hair loss medicines
    • 3.2.2.2. Social stigma associated with hair loss leading to a reluctance to seek treatment
  • 3.2.3. Opportunities
    • 3.2.3.1. Expansion of distribution channels and availability of hair loss medicines in emerging markets
    • 3.2.3.2. Increasing adoption of combination therapies for hair loss treatment
  • 3.2.4. Challenges
    • 3.2.4.1. Limited understanding of the underlying causes of hair loss
• 3.3. Product Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Anti-Hair Loss Medicine Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share and Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Product
    • 4.2.1.1.1. shampoo & conditioner
    • 4.2.1.1.2. oil
    • 4.2.1.1.3. serum
    • 4.2.1.1.4. others
    • 4.2.1.2. Medicine
  • 4.2.2. By Gender
    • 4.2.2.1. Male
    • 4.2.2.2. Female
  • 4.2.3. By End Users
    • 4.2.3.1. Dermatology Clinic
    • 4.2.3.2. Hospitals
    • 4.2.3.3. Home Care Setting
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia Pacific (APAC)
    • 4.2.4.4. Latin America (LATAM)
    • 4.2.4.5. Middle East and Africa (MEA)

5. North America Anti-Hair Loss Medicine Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Gender
  • 5.2.3. By End Users
  • 5.2.4. By Country
    • 5.2.4.1. United States
    • 5.2.4.1.1. By Type
    • 5.2.4.1.2. By Gender
    • 5.2.4.1.3. By End Users
    • 5.2.4.2. Canada
    • 5.2.4.2.1. By Type
    • 5.2.4.2.2. By Gender
    • 5.2.4.2.3. By End Users

6. Europe Anti-Hair Loss Medicine Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Gender
  • 6.2.3. By End Users
  • 6.2.4. By Country
    • 6.2.4.1. Germany
    • 6.2.4.1.1. By Type
    • 6.2.4.1.2. By Gender
    • 6.2.4.1.3. By End Users
    • 6.2.4.2. United Kingdom
    • 6.2.4.2.1. By Type
    • 6.2.4.2.2. By Gender
    • 6.2.4.2.3. By End Users
    • 6.2.4.3. Italy
    • 6.2.4.3.1. By Type
    • 6.2.4.3.2. By Gender
    • 6.2.4.3.3. By End Users
    • 6.2.4.4. France
    • 6.2.4.4.1. By Type
    • 6.2.4.4.2. By Gender
    • 6.2.4.4.3. By End Users
    • 6.2.4.5. Spain
    • 6.2.4.5.1. By Type
    • 6.2.4.5.2. By Gender
    • 6.2.4.5.3. By End Users
    • 6.2.4.6. Belgium
    • 6.2.4.6.1. By Type
    • 6.2.4.6.2. By Gender
    • 6.2.4.6.3. By End Users
    • 6.2.4.7. Russia
    • 6.2.4.7.1. By Type
    • 6.2.4.7.2. By Gender
    • 6.2.4.7.3. By End Users
    • 6.2.4.8. The Netherlands
    • 6.2.4.8.1. By Type
    • 6.2.4.8.2. By Gender
    • 6.2.4.8.3. By End Users
    • 6.2.4.9. Rest of Europe
    • 6.2.4.9.1. By Type
    • 6.2.4.9.2. By Gender
    • 6.2.4.9.3. By End Users

7. Asia-Pacific Anti-Hair Loss Medicine Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Gender
  • 7.2.3. By End Users
  • 7.2.4. By Country
    • 7.2.4.1. China
    • 7.2.4.1.1. By Type
    • 7.2.4.1.2. By Gender
    • 7.2.4.1.3. By End Users
    • 7.2.4.2. India
    • 7.2.4.2.1. By Type
    • 7.2.4.2.2. By Gender
    • 7.2.4.2.3. By End Users
    • 7.2.4.3. Japan
    • 7.2.4.3.1. By Type
    • 7.2.4.3.2. By Gender
    • 7.2.4.3.3. By End Users
    • 7.2.4.4. South Korea
    • 7.2.4.4.1. By Type
    • 7.2.4.4.2. By Gender
    • 7.2.4.4.3. By End Users
    • 7.2.4.5. Australia & New Zealand
    • 7.2.4.5.1. By Type
    • 7.2.4.5.2. By Gender
    • 7.2.4.5.3. By End Users
    • 7.2.4.6. Indonesia
    • 7.2.4.6.1. By Type
    • 7.2.4.6.2. By Gender
    • 7.2.4.6.3. By End Users
    • 7.2.4.7. Malaysia
    • 7.2.4.7.1. By Type
    • 7.2.4.7.2. By Gender
    • 7.2.4.7.3. By End Users
    • 7.2.4.8. Singapore
    • 7.2.4.8.1. By Type
    • 7.2.4.8.2. By Gender
    • 7.2.4.8.3. By End Users
    • 7.2.4.9. Vietnam
    • 7.2.4.9.1. By Type
    • 7.2.4.9.2. By Gender
    • 7.2.4.9.3. By End Users
    • 7.2.4.10. Rest of APAC
    • 7.2.4.10.1. By Type
    • 7.2.4.10.2. By Gender
    • 7.2.4.10.3. By End Users

8. Latin America Anti-Hair Loss Medicine Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Gender
  • 8.2.3. By End Users
  • 8.2.4. By Country
    • 8.2.4.1. Brazil
    • 8.2.4.1.1. By Type
    • 8.2.4.1.2. By Gender
    • 8.2.4.1.3. By End Users
    • 8.2.4.2. Mexico
    • 8.2.4.2.1. By Type
    • 8.2.4.2.2. By Gender
    • 8.2.4.2.3. By End Users
    • 8.2.4.3. Argentina
    • 8.2.4.3.1. By Type
    • 8.2.4.3.2. By Gender
    • 8.2.4.3.3. By End Users
    • 8.2.4.4. Peru
    • 8.2.4.4.1. By Type
    • 8.2.4.4.2. By Gender
    • 8.2.4.4.3. By End Users
    • 8.2.4.5. Rest of LATAM
    • 8.2.4.5.1. By Type
    • 8.2.4.5.2. By Gender
    • 8.2.4.5.3. By End Users

9. Middle East & Africa Anti-Hair Loss Medicine Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Gender
  • 9.2.3. By End Users
  • 9.2.4. By Country
    • 9.2.4.1. Saudi Arabia
    • 9.2.4.1.1. By Type
    • 9.2.4.1.2. By Gender
    • 9.2.4.1.3. By End Users
    • 9.2.4.2. UAE
    • 9.2.4.2.1. By Type
    • 9.2.4.2.2. By Gender
    • 9.2.4.2.3. By End Users
    • 9.2.4.3. Qatar
    • 9.2.4.3.1. By Type
    • 9.2.4.3.2. By Gender
    • 9.2.4.3.3. By End Users
    • 9.2.4.4. Kuwait
    • 9.2.4.4.1. By Type
    • 9.2.4.4.2. By Gender
    • 9.2.4.4.3. By End Users
    • 9.2.4.5. South Africa
    • 9.2.4.5.1. By Type
    • 9.2.4.5.2. By Gender
    • 9.2.4.5.3. By End Users
    • 9.2.4.6. Nigeria
    • 9.2.4.6.1. By Type
    • 9.2.4.6.2. By Gender
    • 9.2.4.6.3. By End Users
    • 9.2.4.7. Algeria
    • 9.2.4.7.1. By Type
    • 9.2.4.7.2. By Gender
    • 9.2.4.7.3. By End Users
    • 9.2.4.8. Rest of MEA
    • 9.2.4.8.1. By Type
    • 9.2.4.8.2. By Gender
    • 9.2.4.8.3. By End Users

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Anti-Hair Loss Medicine Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Anti-Hair Loss Medicine Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Merck & Co., Inc.
• 12.2. Johnson & Johnson
• 12.3. Dr. Reddy's Laboratories Ltd.
• 12.4. Cipla Inc.
• 12.5. Sun Pharmaceutical Industries Ltd.
• 12.6. Histogen Inc.
• 12.7. Concert Pharmaceuticals, Inc.
• 12.8. Aclaris Therapeutics, Inc.
• 12.9. Follicum AB
• 12.10. Polichem S.A.
• 12.11. Cassiopea SpA
• 12.12. PureTech Health
• 12.13. Kythera Biopharmaceuticals, Inc.
• 12.14. Kerastem Technologies
• 12.15. HairClone
• 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations